BioSpace News Archive

The global glaucoma treatment market is competitive in nature with a large number of players operating in it across the globe, states a new market research study by Transparency Market Research.

PureTech Health plc announced that Bharatt Chowrira, J.D., Ph.D., president and chief of business and strategy, will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 12, at 9:10AM EDT.

ENTEROME SA announces that Pierre Belichard, CEO, and Christophe Bonny, CSO, will participate in the BTIG Virtual Biotechnology Conference 2020 which will take place August 10-11th 2020.

Kamada Ltd., plasma-derived biopharmaceutical company, announced that it will release financial results for the second quarter ended June 30, 2020, prior to the open of the U.S. financial markets on Wednesday, August 12, 2020.

In the second quarter the Company was granted approval to market itsCGuard™ MicroNet stent in Brazil and completed an $11.5 million capital raise; reported outstanding results in studies treating patients with the CGuard™ MicroNET stent

Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that it will report financial results for the three and six months ended June 30, 2020 and its business outlook before the market open and host a conference call on Wednesday, August 12, 2020.

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce second quarter 2020 financial results on Wednesday, August 12, 2020.

BrainStorm Cell Therapeutics Inc., a leading developer of cellular therapies for neurodegenerative diseases, announced financial results for the second quarter and first half ended June 30, 2020, and provided a corporate update.

Prostate cancer is a cancer of the prostate gland, which is a part of the male reproductive system.

The global human papillomavirus vaccine market was valued at approximately US$ 2.0 Bn in 2016 is anticipated to register compound annual growth rate of over 5.0% from 2017 to 2025, according to a new report published by Transparency Market Research titled “Human Papillomavirus Vaccine Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”.